EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC 4.0

Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls

Seungyeop Baek, Jinny Claire Lee, Byung Hyun Byun, Su Yeon Park, Jeong Ho Ha, Kyo Chul Lee, Seung-Hoon Yang, Jun-Seok Lee, Seungpyo Hong, Gyoonhee Han, Sang Moo Lim, YoungSoo Kim and 1 more

Experimental Neurobiology · 2025-02-28 · 34 (1) · 1-8

DOI: 10.5607/en25008 ↗

At a glance

Journal article in Experimental Neurobiology, published on 2025-02-28. Written by Seungyeop Baek and 12 co-authors. Institution: Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Korea. Cited 4 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Korea Health Industry Development Institute, National Research Foundation of Korea, Yonsei University.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Subjects

Author keywords

Alzheimer diseaseAmyloidBloodEnzyme-linked immunosorbent assayPlasmaTau

Authors and institutions

  • Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Korea.
  • Department of Nuclear Medicine, Korea Cancer Center Hospital, Seoul 01812, Korea.
  • Department of Neurology, Korea Cancer Center Hospital, Seoul 01812, Korea.
  • Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Korea.
  • Department of Medical Biotechnology, Dongguk University, Seoul 04620, Korea.
  • Department of Pharmacology, Korea University, Seoul 02841, Korea.

Funding

  • Korea Health Industry Development Institute
  • National Research Foundation of Korea
  • Yonsei University

Cite

APA

Baek, S., Lee, J. C., Byun, B. H., Park, S. Y., Ha, J. H., Lee, K. C., Yang, S. H., Lee, J. S., Hong, S., Han, G., Lim, S. M., Kim, Y., & Kim, H. Y. (2025). Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls. Experimental Neurobiology, 34(1), 1-8. https://doi.org/10.5607/en25008

Vancouver

Baek S, Lee JC, Byun BH, Park SY, Ha JH, Lee KC, et al. Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls. Experimental Neurobiology. 2025;34(1):1-8. doi:10.5607/en25008

BibTeX
@article{Baek2025,
  author = {Baek, Seungyeop and Lee, Jinny Claire and Byun, Byung Hyun and Park, Su Yeon and Ha, Jeong Ho and Lee, Kyo Chul and Yang, Seung-Hoon and Lee, Jun-Seok and Hong, Seungpyo and Han, Gyoonhee and Lim, Sang Moo and Kim, YoungSoo and Kim, Hye Yun},
  title = {Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls},
  journal = {Experimental Neurobiology},
  year = {2025},
  volume = {34},
  number = {1},
  pages = {1--8},
  doi = {10.5607/en25008}
}
Start for free →